SXTP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SXTP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
60 Degrees Pharmaceuticals's change in inventory for the quarter that ended in Jun. 2024 was $0.01 Mil. It means 60 Degrees Pharmaceuticals's inventory declined by $0.01 Mil from Mar. 2024 to Jun. 2024 .
60 Degrees Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2023 was $0.21 Mil. It means 60 Degrees Pharmaceuticals's inventory declined by $0.21 Mil from Dec. 2022 to Dec. 2023 .
60 Degrees Pharmaceuticals's Total Inventories for the quarter that ended in Jun. 2024 was $0.43 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. 60 Degrees Pharmaceuticals's Days Inventory for the quarter that ended in Jun. 2024 was 436.48.
Inventory Turnover measures how fast the company turns over its inventory within a year. 60 Degrees Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2024 was 0.21.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. 60 Degrees Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 3.44.
The historical data trend for 60 Degrees Pharmaceuticals's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
60 Degrees Pharmaceuticals Annual Data | |||||||||
Trend | Dec20 | Dec21 | Dec22 | Dec23 | |||||
Change In Inventory | 0.19 | 0.31 | 0.01 | 0.21 |
60 Degrees Pharmaceuticals Quarterly Data | |||||||||||||
Dec20 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Change In Inventory | Get a 7-Day Free Trial | 0.11 | 0.06 | 0.15 | 0.03 | 0.01 |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
60 Degrees Pharmaceuticals (NAS:SXTP) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
60 Degrees Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 0.4305 | / | 0.09 | * | 365 / 4 | |
= | 436.48 |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
60 Degrees Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0.09 | / | 0.4305 | |
= | 0.21 |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
60 Degrees Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0.4305 | / | 0.125 | |
= | 3.44 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Cheryl Xu | director | 1025 CONNECTICUT AVENUE NW, SUITE 1000, WASHINGTON DC 20036 |
Geoffrey S Dow | director, 10 percent owner, officer: CEO and President | 1025 CONNECTICUT AVENUE NW, SUITE 1000, WASHINGTON DC 20036 |
Charles W Allen | director | 1881 N. NASH STREET, UNIT 701, ARLINGTON VA 22209 |
Kentucky Technology Inc. | 10 percent owner | 824 BULL LEA RUN, SUITE 2100, LEXINGTON KY 40511 |
Paul Field | director | 1025 CONNECTICUT AVENUE NW, SUITE 1000, WASHINGTON DC 20036 |
Tyrone Miller | officer: Chief Financial Officer | 1025 CONNECTICUT AVENUE NW, SUITE 1000, WASHINGTON DC 20036 |
Florida State University Research Foundation Inc. | 10 percent owner | 200 LEVY AVENUE, BUILDING A, SUITE 351, TALLAHASSEE FL 32310 |
Bryan Lee Smith | officer: Chief Medical Officer | 1025 CONNECTICUT AVENUE NW, SUITE 1000, WASHINGTON DC 20036 |
Stephen Toovey | director | 1025 CONNECTICUT AVENUE NW, SUITE 100, WASHINGTON DC 20036 |
From GuruFocus
By PRNewswire • 07-14-2023
By Marketwired • 05-20-2024
By Marketwired • 09-06-2024
By Marketwired • 08-06-2024
By Marketwired • 08-30-2023
By Marketwired • 05-15-2024
By Marketwired • 09-04-2024
By Marketwired • 07-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.